03 Profile
Hansard to 11 November 2026 · 31,429 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Clinician · Respiratory (asthma/COPD)
Lisa Lancaster
Dr, chief medical officer at Endeavor BioMedicines
press citation on 1 topic since 8 Sept 2026 · last quoted 8 Sept 2026
02 Quoted on · 1 of 29 topics
Lisa Lancaster: key facts
- Kind of voice
- Clinician
- Role
- Dr, chief medical officer at Endeavor BioMedicines
- Quoted on
- Respiratory (asthma/COPD)
- Tracked press citations
- 1
- Most recently quoted
- 8 Sept 2026
04 On the record · press
What Lisa Lancaster has said
- scientistlive.com1
Where Lisa Lancaster has been quoted
- 01Positive results from Brainomix's AI driven analysis of imaging data for IPF - Scientist Livescientistlive.com · 8 Sept 2026
Verbatim
“The results of Brainomix's post hoc quantitative imaging analysis continue to support taladegib's potential to improve lung structure, reduce fibrosis and improve lung function in patients with IPF. We are impressed with the technology's ability to detect statistically significant changes in a small cohort and over a short treatment duration. These results are a testament to the value of objective, sensitive and reliable endpoints for the de-risking of clinical development, and we look forward to future collaboration opportunities with Brainomix.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Doctors, nurses, allied health professionals and other registered clinicians quoted in a clinical capacity. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 12 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.